The 94 references in paper I. Kozlova A., I. Kharlamova Ye., И. Козлов А., И. Харламова Е. (2009) “Натрийуретические пептиды: биохимия, физиология, клиническое значение // Natriuretic Peptides: Biochemistry, Physiology, Clinical Implication” / spz:neicon:reanimatology:632

1
Андреев Д. А. Натрийуретические пептиды В"типа при сердечной недостаточности: диагностика, оценка прогноза и эффективности лечения. Лабораторная медицина 2003; 6: 42—46.
(check this in PDF content)
2
Сапрыгин Д. Б., Мошина В. А.Клиническое значение определения мозгового натрийуретического пептида (аминотерминального фрагмента) — NT"proBNP, при кардиоваскулярной патологии. Ла" бораторная медицина 2003; 8: 1—8.
(check this in PDF content)
3
Gardner R. S., Henderson G., McDonagh T. A.The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones? J. Heart Lung Transplantation 2005; 24 (3): 303—309.
(check this in PDF content)
4
Хефт А.Лабораторный мониторинг во время операции. В кн.: Ак" туальные проблемы анестезиологии и реаниматологии. Освежаю" щий курс лекций Конгресса Европейского общества анестезиоло" гов (Мюнхен, Германия, 2—12 июня 2007). Пер. с англ. Архангельск; 2008. 26—34.
(check this in PDF content)
5
Henry J. P., Gauer O. H., Reeves J. L.Evidence of the Atrial Location of Receptors Influencing Urine Flow. Circulat. Res. 1956; 4 (1): 85—90.
(check this in PDF content)
6
Cantin M., Genest J.The heart as an endocrine gland. Clin. Invest. Med. 1986; 9 (4): 319—327.
(check this in PDF content)
7
DeBold A. J., Flynn T. G. Cardionatrin I — a novel heart peptide with potent diuretic and natriuretic properties. Life Sci. 1983; 33 (3): 297—302.
(check this in PDF content)
8
Kangava K., Fukuda A., Kubota I. et al. Human atrial natriuretic polypeptides (HANP): purification, structure synthesis and biological activity. J. Hypertens Suppl. 1984; 2 (3): 321—323.
(check this in PDF content)
9
Sudoh T., Kangava K., Minamino N., Matsuo H.A new natriuretic pep" tide in porcine brain. Nature 1988; 332 (6159): 78—81.
(check this in PDF content)
10
Nakao K., Ogawa Y., Suga S., Imura H.Molecular biology and biochem" istry of the natriuretic peptide system. II: Natriuretic peptide receptors. J. Hypertens. 1992; 10 (10): 1111—1114.
(check this in PDF content)
11
Hall C. Essential biochemistry and physiology of (NT"pro)BNP. Eur. J. Heart Failure 2004; 6 (3): 257—260.
(check this in PDF content)
12
Maack T.The Broad homeostatic role of natriuretic peptides. Arq. Bras. Endocrinol. Metab. 2006; 50 (2): 198—207.
(check this in PDF content)
13
Ogawa Y., Itoh H., Nakao K. Molecular biology and biochemistry of natri" uretic peptide family. Clin. Exp. Pharmacol. Physiol. 1995; 22 (1): 49—53.
(check this in PDF content)
14
Levin E., Gardner D., Samson W. Natriuretic peptides. N. Engl. J. Med. 1998; 339 (5): 321—328.
(check this in PDF content)
15
Va n d e n B e r g M . , T j e e r d s m a G . , J a n d e K a m P. e t a l . Longstanding atrial fib" rillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure. Eur. J. Heart Fail. 2002; 4 (3): 255—262.
(check this in PDF content)
16
Hystad M. E., Geiran O. R., Attramadal H. et al.Regional cardiac expres" sion and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol. Scand. 2001; 171 (4): 395—403.
(check this in PDF content)
17
Ts u r u d a T . , B o e r r i g t e r G . , H u n t l e y B . K . e t a l .Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ. Res. 2002; 91 (12): 1127—1134.
(check this in PDF content)
18
Va n d e r h e y d e n M . , B a r t u n e k J . , G o e t h a l s M . Brain and other natriuretic peptides: molecular aspects. Eur. J. Heart Failure 2004; 6 (3): 261—268.
(check this in PDF content)
19
Lam C., Burnett J., Costello!Boerrigter L. et al.Alternate circulating pro" B"type natriuretic peptide and B"type natriuretic peptide forms in the general population. JACC 2007; 49 (11): 1193—1202.
(check this in PDF content)
20
Goetze J. P., Christoffersen C., Perko M. et al.Increased cardiac BNP expression associated with myocardial ischemia. The FASEB J. express article. 2003; 17 (9): 1105—1107.
(check this in PDF content)
21
Ve s e l y D . L . Natriuretic peptides and acute renal failure. Am. J. Physiol. Renal Physiol. 2003; 285 (2): F167—F177.
(check this in PDF content)
22
Koller K., Goeddel D. Molecular biology of the natriuretic peptides and their receptors. Circulation 1992; 86 (4): 1081—1088.
(check this in PDF content)
23
Porter J. G., Arfsten A., Fuller F. et al.Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem. Biophys. Res. Commun. 1990; 171 (2): 796—803.
(check this in PDF content)
24
Kone B. C.Molecular biology of natriuretic peptides and nitric oxide synthases. Cardiovasc. Res. 2001; 51 (3): 429—441.
(check this in PDF content)
25
Goy M., Oliver P., Purdy K. et al.Evidence for a novel natriuretic pep" tide receptor that prefers brain natriuretic peptide over atrial natri" uretic peptide. Biochem. J. 2001; 358 (Pt. 2): 379—387.
(check this in PDF content)
26
Hunt P., Espiner E., Nicholls M. et al. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. J. Clin. Endocrinol. Metab. 1996; 81 (11): 3871—3876.
(check this in PDF content)
27
Va l l i N . , G o b i n e t A . , B o r d e n a v e L .Review of 10 years of the clinical use of brain natriuretic peptidein cardiology. J. Lab. Clin. Med. 1999; 134 (5): 437—444.
(check this in PDF content)
28
Almeida F. A., Suzuki M., Maack T.Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats. Life Sci. 1986; 39 (13): 1193—1199.
(check this in PDF content)
29
Tr i p p o d o N . C . , B a r b e e R . W . Atrial natriuretic factor decreases whole" body capillary absorption in rats. Am. J. Physiol. 1987; 252 (5): 915—920.
(check this in PDF content)
30
Huxley V. H., Tucker V. L., Verburg K. M., Freeman R. H. Increased capil" lary hydraulic conductivity induced by atrial natriuretic peptide. Circulat. Res. 1987; 60 (2): 304—307.
(check this in PDF content)
31
Melo L., Steinhelper M., Pang S. C. et al.ANP in regulation of arterial pressure and fluid"electrolyte balance: lessons from genetic mouse mod" els. Physiol. Genomics 2000; 3 (1): 45—58.
(check this in PDF content)
32
Atchison D. J., Johnston M. G.Atrial natriuretic peptide attenuates flow in an isolated lymph duct preparation. Pflügers Arch. 1996; 431 (4): 618—624.
(check this in PDF content)
33
Ya n g R . H . , J i n H . K . , W y s s J . M . e t a l .Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii. Hypertension 1992; 19 (2): 198—205.
(check this in PDF content)
34
Lappe R. W., Smits J. F., Todt J. A. et al. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat. Circ. Res. 1985; 56 (4): 606—612.
(check this in PDF content)
35
Furuya M., Aisaka K., Miyazaki T. et al.C"type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem. Biophys. Res. Commun. 1993; 193 (1): 248—253.
(check this in PDF content)
36
Holtwick R., van Eickels M., Skryabin B. V. et al.Pressure"independent cardiac hypertrophy in mice with cardiomyocyte"restricted inactiva" tion of the atrial natriuretic peptide receptor guanylcyclase"A. J. Clin. Invest. 2003; 111 (9): 1399—1407.
(check this in PDF content)
37
Oliver P. M., Fox J. E., Kim R. et al.Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. USA 1997; 94 (26): 14730—14735.
(check this in PDF content)
38
Kapoun A. M., Liang F., O'Young G. et al.B"type natriuretic peptide exerts broad functional opposition to transforming growth factor beta in primary human cardiac fibroblasts: Fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ. Res. 2004; 94 (4): 453—461.
(check this in PDF content)
39
Marin!Grez M., Fleming J. T., Steinhausen M. Atrial natriuretic peptide causes pre"glomerular vasodilatation and post"glomerular vasocon" striction in rat kidney. Nature 1986; 324 (6096): 473—476.
(check this in PDF content)
40
We i d m a n P. , H a s l e r L . , G n a d i n g e r M . e t a l . Blood levels and renal effects of atrial natriuretic peptide in normal man. J. Clin. Invest. 1986; 77 (3): 734—742.
(check this in PDF content)
41
Fried T. A., McCoy R. N., Osgood R. W., Stein J. H.Effect of angiopeptin III on determinants of glomerular filtration rate in the in vitro perfused dog glomerulus. Am. J. Physiol. 1986; 250 (6 Pt 2): 1119—1122.
(check this in PDF content)
42
Stockand J. D., Sansom S. C. Regulation of filtration rate by glomerular mesangial ceels in health and diabetic renal disease. Am. J. Kidney Dis. 1997; 29 (6): 971—981.
(check this in PDF content)
43
Harris P. J., Thomas D., Morgan T. O.Atrial natriuretic peptide inhibits angiotensin"stimulated proximal tubular sodium and water reabsorp" tion. Nature 1987; 326 (6114): 697—698.
(check this in PDF content)
44
Zeidel M. L.Regulation of collecting duct Na reabsorption by ANP 31"67. Clin. Exp. Pharmacol. Physiol. 1995; 22 (2): 121—124.
(check this in PDF content)
45
Hunt P. J., Richards A. M., Espiner E. A. et al. Bioactivity and metabolism of C"type natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 1994; 78 (6): 1428—1435.
(check this in PDF content)
46
Blackburn R. E., Samson W. K., Fulton R. J. et al.Central oxytocin and ANP receptors mediate osmotic inhibition of salt appetite in rats. Am. J. Physiol. 1995; 269 (2 Pt 2): R245—R251.
(check this in PDF content)
47
Gardi J., Biro E., Vecsernyes M. et al.The effects of brain and C"type natriuretic peptides on corticotrophin"releasing factor in brain of rats. Life Sci. 1997; 60 (23): 2111—2117.
(check this in PDF content)
48
Guild S., Gramb G.Characterisation of the effects of natriuretic pep" tides upon ACTH secretion from the mouse pituitary. Molec. Cell. Endocrinol. 1999; 152 (1—2): 11—19.
(check this in PDF content)
49
Nawata M., Ohashi M., Haji M. et al. Atrial and brain natriuretic pep" tide in adrenal steroidogenesis. J. Steroid Biochem. Molec. Biology 1991; 40 (1—3): 367—379.
(check this in PDF content)
50
Niina H., Kobayashi H., Yamamoto R. et al.Receptors for atrial natri" uretic peptide in adrenal chromaffin cells. Biochemical Pharmacology 1996; 51 (6): 855—858.
(check this in PDF content)
51
Dessi!Fulgheri P., Sarzani R., Rappelli A. Role of the natriuretic peptide system in lipogenesis/lipolysis. Nutr. Metabol. Cardiovasc. Disease 2003; 13 (4): 244—249.
(check this in PDF content)
52
Jankowski M., Petrone C., Tremblay J., Gutkowska J. Natriuretic peptide system in the rat submaxillary gland. Regulatory Peptides 1996; 62 (1): 53—61.
(check this in PDF content)
53
Cleland J., Ward S., Dutka D. et al. Stability of plasma concentrations of N and C"terminal atrial natriuretic peptides at room temperature. Heart 1996; 74 (4): 410—413
(check this in PDF content)
54
Hunt P. J., Yandle T. G., Nicholls M. G. et al. The amino"terminal portion of pro"brain natriuretic peptide (Pro"BNP) circulates in human plasma. Biochem. Byophys. Res. Commun. 1995; 214 (3): 1175—1183.
(check this in PDF content)
55
Ationu A., Burch M., Elliott M., Carter N.Brain natriuretic peptide and fluid volume homeostasis"studies during cardiopulmonary bypass surgery. Clin. Auton. Res. 1993; 3 (4): 275—280.
(check this in PDF content)
56
Yu C . , S a n d e r s o n J .Plasma brain natriuretic peptide"an independent predictor of cardiovascular mortality in acute heart failure. Eur. J. Heart Failure 1999; 1 (1): 59—65.
(check this in PDF content)
57
Groenning B., Nilsson J., Sondergaard L. et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multi" ple neurohumoral plasma concentrations. Eur. J. Heart Fail. 2001; 3 (6): 699—708.
(check this in PDF content)
58
Missouris C., Varma C., Ward D., MacGregor G.Cardiac peptides and plasma rennin activity in acute dilated cardiomyopathy. Eur. J. Heart Fail. 2001; 3 (1): 109—111.
(check this in PDF content)
59
Seino Y., Ogawa A., Yamashita T. et al. Application of NT"proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur. J. Heart Fail. 2004; 6 (3): 295—300.
(check this in PDF content)
60
Te o d o r o v i c h N . , K r a k o v e r R . , Ve r e d Z .B"Type natriuretic peptide: a uni" versal cardiac biomarker? Isr. Med. Assoc. J. 2008; 10 (2): 152—153.
(check this in PDF content)
61
Wieczorek S. J., Wu A. H., Christenson R. et al.A rapid B"type natriuret" ic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am. Heart J. 2002; 144 (5): 834—839.
(check this in PDF content)
62
Шумаков В. И., Шевченко О. П., Орлова О. В. и соавт.Мозговой и предсердный натрийуретические пептиды при трансплантации ау" тологичных клеток костного мозга больным с сердечной недоста" точностью. Вестн. трансплантологии и искусств. органов 2006; 1: 41—48.
(check this in PDF content)
63
Alibay Y., Beauchet A., El Mahmoud R. et al. Plasma N"terminal pro" brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Biomed. Pharmacother. 2005; 59 (1—2): 20—24.
(check this in PDF content)
64
Le Jemtel T. H., Padeletti M., Jelic S. Diagnostic and therapeutic chal" lenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J. Am. Coll. Cardiol. 2007; 49 (2): 171—180.
(check this in PDF content)
65
Maeda K., Tsutamoto T., Wada A. et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end diastolic pressure in patients with symptomatic left ventricular dysfunction. Am. Heart J. 1998; 135 (5 Pt 1): 825—832.
(check this in PDF content)
66
Battaglia M., Pewsner D., Juni P. et al.Accuracy of B"type natri" uretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. Arch. Intern. Med. 2006; 166 (10): 1073—1080.
(check this in PDF content)
67
McDonagh T., Holmer S., Raymond I. et al.NT"proBNP and the diagno" sis of heart failure: a pooled analysis of three European epidemiological studies. Eur. J. Heart Failure 2004; 6 (3): 269—274.
(check this in PDF content)
68
We b e r M . , H a m m C .Role of B"type natriuretic peptide(BNP) and NT" proBNP in clinical routine. Heart 2006; 92 (6): 843—849.
(check this in PDF content)
69
Dahlstrom U.Can natriuretic peptides be used for the diagnosis of dias" tolic heart failure? Eur. J. Heart Failure 2004; 6 (3): 281—287.
(check this in PDF content)
70
Iwanaga Y., Nishi I., Furuichi S. et al.B"type natriuretic peptide strong" ly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J. Am. Coll. Cardiol. 2006; 47 (4): 742—748.
(check this in PDF content)
71
Tr o u g h t o n R . W . , F r a m p t o n C . M . , Ya n d l e T . G . e t a l .Treatment of heart fail" ure guided by plasma aminoterminal brain natriuretic peptide (N"BNP) concentrations. Lancet 2000; 355 (9210): 1126—1130.
(check this in PDF content)
72
Wu A. H. Serial testing of B"type natriuretic peptide and NT"proBNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am. Heart J. 2006; 152 (5): 828—834.
(check this in PDF content)
73
Omland T., Aakvaag A., Bonarjee V. V. S. et al.Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long" term survival after acute myocardial infarction. Circulation 1996; 93 (11): 1963—1969.
(check this in PDF content)
74
Grabowski M., Filipiak K. J., Karpinski G. et al.Serum B"type natriuret" ic peptide levels on admission predict not only short"term death but also angiographic success of procedure in patients with acute ST"eleva" tion myocardial infarction treated with primary angioplasty. Am. Heart J. 2004; 148 (4): 655—662.
(check this in PDF content)
75
Mega J. L., Morrow D. A., De Lemos J. A. et al.B"type natriuretic peptide at presentation and prognosis in patients with ST"segment elevation myocardial infarction: an ENTIRE"TIMI"23 substudy. J. Am. Coll. Cardiol. 2004; 44 (2): 335—339.
(check this in PDF content)
76
Omland T., Sabatine M. S., Jablonski K. A. et al.Prognostic value of B" type natriuretic peptides in patients with stable coronary artery dis" ease: the PEACE Trial. J. Am. Coll. Cardiol. 2007; 50 (3): 205—214.
(check this in PDF content)
77
Galvani M., Ferrini D., Ottani F.Natriuretic peptides for risk stratifica" tion of patients with acute coronary syndromes. Eur. J. Heart Failure 2004; 6 (3): 327—334.
(check this in PDF content)
78
Hong S. N., Ahn Y., Hwang S. H. et al.Usefulness of preprocedural N"ter" minal pro"brain natriuretic peptide in predicting angiographic no" reflow phenomenon during stent implantation in patients with ST"seg" ment elevation acute myocardial infarction. Am. J. Cardiol. 2007; 100 (4): 631—634.
(check this in PDF content)
79
Binder J., Ommen S. R., Chen H. H. et al. Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy. Am. J. Cardiol. 2007; 100 (4): 712—714.
(check this in PDF content)
80
Reesink H. J., Tulevski I. I., Marcus J. T. et al. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Ann. Thorac. Surg. 2007; 84 (2): 537—543.
(check this in PDF content)
81
Ationu A., Singer D. R., Smith A. et al.Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. Cardiovasc. Res. 1993; 27 (8): 1538—1541.
(check this in PDF content)
82
Hata M., Masato O., Cho S. et al. A correlation between atrial natriuret" ic peptide, brain natriuretic peptide, and perioperative cardiac and renal functions in open heart surgery. Nippon Kyobu Geka Gakkai Zasshi 1997; 45 (11): 1797—1802.
(check this in PDF content)
83
Morimoto K., Mori T., Ishiguro S. et al.Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg. Today 1998; 28 (1): 23—29.
(check this in PDF content)
84
Matsushita Y., Okamura Y., Iida H. et al.Usefulness of OPCAB from the viewpoint of fluctuations in the level of blood natriuretic peptides. Ky o b u G e k a . 2 0 0 1 ; 5 4 ( 4 ) : 3 2 1 — 3 2 5 .
(check this in PDF content)
85
Sodian R., Loebe M., Schmitt C. et al.Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J. Am. Coll. Cardiol. 2001; 38 (7): 1942—1949.
(check this in PDF content)
86
Hutfless R., Kazanegra R., Madani M. et al.Utility of B"type natriuret" ic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J. Am. Coll. Cardiol. 2004; 43 (10): 1873—1879.
(check this in PDF content)
87
Шумаков Д. В., Шевченко О. П., Орлова О. В. и соавт.Прогностиче" ское значение натрийуретического пептида В"типа у кардиохирур" гических больных. Вестн. трансплантологии и искусств. органов 2007; 1: 54—61.
(check this in PDF content)
88
Saribulbul O., Alat I., Coskun S. et al. The role of brain natriuretic pep" tide in the predicting performance in coronary artery bypass grafting. Te x . H e a r t I n s t . J . 2 0 0 3 ; 3 0 ( 4 ) : 2 9 8 — 3 0 4 .
(check this in PDF content)
89
Berendes E., Schmidt C., Van Aken H. et al.A"Type and B"Type natri" uretic peptides in cardiac surgical procedures. Anesth. Analg. 2004; 98 (1): 11—19.
(check this in PDF content)
90
Wa t a n a b e M . , M u r a k a m i M . , F u r u k a w a H . , N a k a h a r a H .Is measurement of plasma brain natriuretic peptide levels a useful test to detect for sur" gical timing of valve disease? Int. J. Cardiol. 2004; 96 (1): 21—24.
(check this in PDF content)
91
Мочкин И. А., Шумаков Д. В.Прогностическое и диагностическое значение уровня МНП в плазме при выполнении операций прямой реваскуляризации миокарда в условиях искусственного кровооб" ращения. Лаборатория 2005; 1: 6—7.
(check this in PDF content)
92
Wa z n i O . , M a r t i n D . , M a r r o u c h e N . e t a l . Plasma B"Type natriuretic pep" tide levels predict postoperative atrial fibrillation in patients undergo" ing cardiac surgery. Circulation 2004; 110 (2): 124—127.
(check this in PDF content)
93
Hajjar L., Galas F., Grande S. et al.Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: associa" tion with cardiovascular death, postoperative cardiac, renal and pul" monary dysfunction. Crit. Care 2008; 12 (Suppl 2): 444.
(check this in PDF content)
94
Provenchere S., Berroeta C., Reynaud C. et al.Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1"year mortality. Crit. Care Med. 2006; 34 (4): 995—1000. Поступила 29.10.08
(check this in PDF content)